In recognition of National Women's Health Week (May 14-20, 2023) Patient Care editors collected some of the most notable studies, FDA actions, and expert guidance updates from the second quarter of 2023, so far.
Topics include earlier screening for breast cancer, persistently higher post-MI adverse events in women vs men, migraine history and pregnancy complications, and more.
Find highlights of 9 top news items here and links for more information for all.
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.